<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02506244</url>
  </required_header>
  <id_info>
    <org_study_id>Version 3.5</org_study_id>
    <nct_id>NCT02506244</nct_id>
  </id_info>
  <brief_title>mHealth Screening to Prevent Strokes</brief_title>
  <acronym>mSToPS</acronym>
  <official_title>mHealth Screening to Prevent Strokes (mSToPS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scripps Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Scientific Affairs, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aetna, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Scripps Translational Science Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether it is possible to identify a high-risk&#xD;
      cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and&#xD;
      then engage those individuals in a mobile health technology-enabled home monitoring program&#xD;
      in order to document previously undiagnosed atrial fibrillation, and provide clinical&#xD;
      evidence of an outcomes benefit associated with this early detection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to propose to study two different methods of intermittent rhythm&#xD;
      monitoring in a cohort of individuals without prior history of atrial fibrillation, but&#xD;
      determined to be at increased risk based on clinical risk factors, and compare the rate of&#xD;
      atrial fibrillation detection through monitoring relative to routine care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of newly diagnosed AF</measure>
    <time_frame>End of 4 month monitoring period</time_frame>
    <description>Incidence of newly diagnosed AF as defined by at least 30 seconds of AF or atrial flutter at the end of the 4 month monitoring period compared to the delayed monitoring cohort (primary) and observational control (secondary)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of atrial fibrillation</measure>
    <time_frame>1 year</time_frame>
    <description>Comparison of the rate of newly diagnosed AF in the entire monitored cohort compared to that in the matched cohort.&#xD;
Difference in healthcare utilization/costs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first event of the combined endpoint of stroke, systemic emboli, or MI in patients diagnosed with AF in monitored vs. control cohorts.</measure>
    <time_frame>3 years</time_frame>
    <description>Clinical outcomes will be determined using claims data and compared between the monitored and observational cohorts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in total healthcare costs in AF cohorts of monitored and controls</measure>
    <time_frame>3 years</time_frame>
    <description>Evaluation if there is a difference in healthcare costs with monitored individuals compared to controls with respect to AF</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2274</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Immediate Monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals randomized to immediate monitoring will receive the ZIO XT patch sensor and wear it for the first and last 2 week period of the 4 month monitoring period of time 0 to 4 months.&#xD;
Note: Approximately 250 consenting participants will also be invited to participate in a sub-study to wear an additional monitoring device (Amiigo wristband) continuously over the 4 month monitoring period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Individuals randomized to delayed monitoring will receive usual care for 4 months after which they will receive the ZIO XT patch sensor and wear it for the first and last 2 week period of study months 4 through 8.&#xD;
Note: Approximately 250 consenting participants will also be invited to participate in a sub-study to wear an additional monitoring device (Amiigo wristband) daily for months 4 through 8.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iRhythm ZIO XT Patch</intervention_name>
    <description>Single-lead ECG monitoring via a wearable patch</description>
    <arm_group_label>Delayed Monitoring</arm_group_label>
    <arm_group_label>Immediate Monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wristband by Amiigo</intervention_name>
    <description>Determines pulse rate using photoplethysmography.</description>
    <arm_group_label>Delayed Monitoring</arm_group_label>
    <arm_group_label>Immediate Monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Participants:&#xD;
&#xD;
        The study population will be derived from the Aetna and Medicare populations.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or females age &gt; 75 or&#xD;
&#xD;
          -  Male age &gt; 55, or females age &gt; 65, and&#xD;
&#xD;
          -  Prior CVA, or&#xD;
&#xD;
          -  Heart failure, or&#xD;
&#xD;
          -  Diagnosis of both diabetes and hypertension, or&#xD;
&#xD;
          -  Mitral valve disease, or&#xD;
&#xD;
          -  Left ventricular hypertrophy, or&#xD;
&#xD;
          -  COPD requiring home O2, or&#xD;
&#xD;
          -  Sleep apnea, or&#xD;
&#xD;
          -  History of pulmonary embolism, or&#xD;
&#xD;
          -  History of myocardial infarction, or&#xD;
&#xD;
          -  Diagnosis of obesity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or prior diagnosis of atrial fibrillation, atrial flutter or atrial&#xD;
             tachycardia&#xD;
&#xD;
          -  Receiving chronic anticoagulation therapy&#xD;
&#xD;
          -  Hospice care&#xD;
&#xD;
          -  End stage renal disease&#xD;
&#xD;
          -  Diagnosis of moderate or greater dementia&#xD;
&#xD;
          -  Implantable pacemaker and/or defibrillator&#xD;
&#xD;
          -  History of skin allergies to adhesive patches&#xD;
&#xD;
          -  Known metastatic cancer&#xD;
&#xD;
          -  Aetna Compassionate Care Program (ACCP) participants - individuals with advanced&#xD;
             illness and limited life expectancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven R Steinhubl</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Scripps Translational Science Institute</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 17, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2015</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Scripps Translational Science Institute</investigator_affiliation>
    <investigator_full_name>Steven Steinhubl</investigator_full_name>
    <investigator_title>Director, Digital Medicine</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Wearable device</keyword>
  <keyword>Wristband</keyword>
  <keyword>ECG Patch</keyword>
  <keyword>Strokes</keyword>
  <keyword>Asymptomatic</keyword>
  <keyword>Heart Rhythm</keyword>
  <keyword>Home Monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

